Delivering safe in vivo cell & gene therapies to make challenging diseases curable – for everyone

Transparent bubbles float against a blue background, with light reflections and blurring.

The TQx Trinity

The TQx CELLfinity platform based on our highly automated EXiVO approach, is shifting the less scalable, lengthy and cost-intensive “classical” pharmaceutical production of cell therapeutics to deliver safe in vivo cell & gene therapies that is based on our proprietary EXiVO approach, without abandoning the advantages of autologous cell therapy.